ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 39 filers reported holding ZAI LAB LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,191 | +101.9% | 35,807 | +86.5% | 0.01% | +100.0% |
Q4 2022 | $590 | -99.9% | 19,203 | -34.4% | 0.01% | -41.7% |
Q3 2022 | $1,001,000 | -34.5% | 29,256 | -33.6% | 0.01% | -25.0% |
Q2 2022 | $1,528,000 | +376.0% | 44,062 | +503.3% | 0.02% | +700.0% |
Q1 2022 | $321,000 | -83.8% | 7,304 | -76.8% | 0.00% | -81.8% |
Q4 2021 | $1,978,000 | -57.8% | 31,464 | -29.2% | 0.01% | -50.0% |
Q3 2021 | $4,686,000 | -35.9% | 44,464 | +7.6% | 0.02% | -35.3% |
Q2 2021 | $7,312,000 | +436.1% | 41,312 | +304.1% | 0.03% | +385.7% |
Q1 2021 | $1,364,000 | -74.7% | 10,222 | -74.4% | 0.01% | -75.9% |
Q4 2020 | $5,395,000 | +205.5% | 39,863 | +87.7% | 0.03% | +163.6% |
Q3 2020 | $1,766,000 | +66.8% | 21,234 | +64.6% | 0.01% | +22.2% |
Q2 2020 | $1,059,000 | +339.4% | 12,897 | +175.5% | 0.01% | +350.0% |
Q1 2020 | $241,000 | -70.7% | 4,681 | -87.9% | 0.00% | -71.4% |
Q1 2018 | $823,000 | +1.6% | 38,552 | +1.0% | 0.01% | -12.5% |
Q4 2017 | $810,000 | -63.1% | 38,156 | -53.1% | 0.01% | -57.9% |
Q3 2017 | $2,198,000 | – | 81,405 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |